In cancer care, precision isn’t just a buzzword; it’s a lifeline. Knowing exactly where cancer is, how active it is, and how it's responding to treatment can mean the difference between a plan that works and one that falls short. That’s where PET-CT comes in, not just as a scan, but as a powerful tool for personalised treatment planning for the cancers where it’s appropriate.

By combining functional and anatomical imaging, PET-CT gives doctors the kind of clarity that guides more accurate decisions, reduces unnecessary interventions, and ensures care is tailored to the individual.

From one-size-fits-all to made-for-you

For decades, many cancer treatments followed a relatively standard path. Once diagnosed, patients might receive a combination of surgery, chemotherapy, or radiation based on the cancer type and stage. But medicine is evolving, and so is our ability to customise care.

By showing where cancer is active and how it’s behaving in real time, PET-CT allows doctors to:

• Fine-tune treatment plans before they begin,
• Assess treatment response early on, and
• Adapt strategies quickly if the current approach isn’t working.

Why precision matters

Treating cancer isn’t just about attacking the disease; it’s about doing so in a way that protects as much of the healthy body as possible. That balance relies on accurate information.

For certain cancers, PET-CT helps provide that by:

• Mapping the full extent of disease: Identifying both visible tumours and hidden cancer cells that might not show up on conventional scans.
• Avoiding overtreatment: For example, by showing when cancer hasn’t spread as far as suspected, allowing for a less aggressive approach.
• Highlighting when more is needed: Such as when active cancer is detected beyond the primary site, indicating the need for systemic therapy.

This level of insight means treatments can be targeted more precisely, whether it’s radiation directed only at active areas, or chemotherapy chosen based on how the body is responding.

Mid-treatment insights that matter

One of the most powerful uses of PET-CT is assessing the effectiveness of treatment before the full course is completed.

By performing a scan partway through treatment, doctors can see whether cancer activity is decreasing. If it is, that’s encouraging. If not, the care team may decide to switch strategies, escalate treatment, or consider alternative therapies.

Personalised care. Human impact.

Personalised treatment planning means:

• Fewer unnecessary procedures, side effects, or delays.
• More confidence in the care plan, knowing it’s based on what’s really happening in your body.
• A sense of control at a time when things can feel unpredictable.

Every person’s cancer journey is different. PET-CT helps ensure that the path forward reflects this, offering a more tailored approach.

Technology that sees more so you don’t have to guess

At Life Healthcare, our PET-CT technology is part of a broader mission: to deliver care that is not only cutting-edge but deeply personal.

We work closely with referring doctors, oncologists, and multidisciplinary teams to ensure that PET-CT scans are used thoughtfully, when they add the most value, and when they can make the biggest difference in guiding care.

Whether it’s deciding if radiation is needed, choosing between treatment options, or identifying how well a therapy is working, PET-CT provides the kind of insight that supports not just treatment but trust.
Reimagining what cancer care can be

Reimagining what cancer care can be

PET-CT may be a scan, but its impact is far greater. It’s helping to rewrite the cancer care journey.
If you’re undergoing cancer treatment, or supporting someone who is, know that PET-CT is one of the tools helping doctors see the full picture. And when your team sees more clearly, you can move forward with greater clarity, confidence, and care.